We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.92B
AUM Growth
+$705M
Cap. Flow
+$556M
Cap. Flow %
11.29%
Top 10 Hldgs %
30.88%
Holding
109
New
27
Increased
28
Reduced
31
Closed
16

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$201M
2
VTRS icon
Viatris
VTRS
+$197M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$167M
4
ELV icon
Elevance Health
ELV
+$92.3M
5
THC icon
Tenet Healthcare
THC
+$70.7M

Top Sells

Rank Stock Value
1
JUNO
Juno Therapeutics, Inc.
JUNO
+$84.6M
2
NOW icon
ServiceNow
NOW
+$80.6M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$73.7M
4
CI icon
Cigna
CI
+$60.3M
5
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 59.98%
2 Technology 11.1%
3 Communication Services 4.51%
4 Financials 2.87%
5 Consumer Discretionary 2.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RHT
51
DELISTED
Red Hat Inc
RHT
$38.7M 0.79%
+258,660
New +$35.9M
DXCM icon
52
DexCom
DXCM
$31.5B
$38.1M 0.77%
+2,056,656
New +$30.4M
ATVI
53
DELISTED
Activision Blizzard
ATVI
$36.4M 0.74%
540,254
-155,897
-22% -$11M
ELGX
54
DELISTED
Endologix Inc
ELGX
$32.8M 0.67%
774,293
+23,302
+3% +$1M
ARAY icon
55
Accuray
ARAY
$32M
$32.1M 0.65%
6,424,070
+2,047,492
+47% +$10.7M
ALDR
56
DELISTED
Alder Biopharmaceuticals
ALDR
$31.7M 0.64%
+2,496,827
New +$36.1M
ICLR icon
57
Icon
ICLR
$12.6B
$31.7M 0.64%
268,353
-62,626
-19% -$7.18M
SNNA
58
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$29.1M 0.59%
1,551,176
-76,966
-5% -$1.35M
KURA icon
59
Kura Oncology
KURA
$800M
$25.1M 0.51%
1,339,362
-412,762
-24% -$8.03M
COUP
60
DELISTED
Coupa Software Incorporated
COUP
$25M 0.51%
548,371
+205,646
+60% +$8.45M
RGNX icon
61
Regenxbio
RGNX
$620M
$23.7M 0.48%
793,951
+24,156
+3% +$703K
NFLX icon
62
Netflix
NFLX
$299B
$23.5M 0.48%
795,910
-675,710
-46% -$18.4M
BLUE
63
DELISTED
bluebird bio
BLUE
$21.9M 0.45%
9,908
-884
-8% -$2.25M
DBX icon
64
Dropbox
DBX
$7.6B
$21.3M 0.43%
+681,302
New +$20.6M
CUTR
65
DELISTED
Cutera, Inc.
CUTR
$20.1M 0.41%
400,726
-14,089
-3% -$688K
BSX icon
66
Boston Scientific
BSX
$69.5B
$19.7M 0.4%
+719,302
New +$19.5M
TSLA icon
67
Tesla
TSLA
$1.23T
$19.3M 0.39%
1,088,055
-152,445
-12% -$3.35M
SYNH
68
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$19.2M 0.39%
540,984
+227,727
+73% +$8.92M
CSII
69
DELISTED
Cardiovascular Systems, Inc.
CSII
$18M 0.37%
821,154
+271,497
+49% +$6.53M
PTLA
70
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$17.4M 0.35%
+533,300
New +$23.4M
TREE icon
71
LendingTree
TREE
$447M
$16.8M 0.34%
51,208
-14,132
-22% -$5.09M
NVDA icon
72
NVIDIA
NVDA
$4.86T
$15.4M 0.31%
2,664,080
-3,117,240
-54% -$18.3M
ALNA
73
DELISTED
Allena Pharmaceuticals
ALNA
$15.2M 0.31%
1,463,894
-310
-0% -$2.59K
NITE
74
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$14.5M 0.29%
1,009,973
+30,580
+3% +$417K
RCUS icon
75
Arcus Biosciences
RCUS
$3.55B
$14.4M 0.29%
+933,286
New +$15.5M
1 2
3
4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q1 2018 Portfolio in Review

As of Q1 2018, PFM Health Sciences held 109 positions worth $4.92B, up 17% from $4.22B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

PFM Health Sciences deployed $556M of net new capital in Q1 2018, opening 27 new positions and adding to 28 existing holdings. Its largest new stake was Bristol-Myers Squibb: 3,123,145 shares worth $198M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 48% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was ServiceNow, an estimated $80.6M trimmed.

  • PFM Health Sciences's largest Q1 2018 buy was Bristol-Myers Squibb: 3,123,145 shares worth $198M.
  • PFM Health Sciences added most to Elevance Health in Q1 2018, an estimated $92.3M increase.
  • PFM Health Sciences's biggest Q1 2018 reduction was ServiceNow, cutting an estimated $80.6M.
  • PFM Health Sciences fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $84.6M.
  • PFM Health Sciences's ten largest holdings make up 31% of its $4.92B portfolio in Q1 2018.
  • PFM Health Sciences opened 27 new positions and closed 16 in Q1 2018.
  • PFM Health Sciences's portfolio value rose 17% quarter-over-quarter to $4.92B.

Based on PFM Health Sciences's 13F filing for Q1 2018, filed 15 May 2018.